China SXT Pharmaceuticals
SXTC
1 hedge funds and large institutions have $13.1K invested in China SXT Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
159% more capital invested
Capital invested by funds: $5.08K → $13.1K (+$8.06K)
0% more funds holding
Funds holding: 1 → 1 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$18.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$5.08K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $13.1K | +$18.2K | +35 | New |
|
|
2
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$5.08K | -8 | Closed |
|
SXTC Hedge Fund Activity: Q1 2025 in Review
1 of the 7,461 institutional investors tracked by Wall St. Rank reported a position in China SXT Pharmaceuticals (SXTC) for Q1 2025, worth a combined $13.1K — up 159% from $5.08K a quarter earlier.
Fund positioning in SXTC was balanced in Q1 2025: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $18.2K. The largest seller was Bank of Montreal, exiting entirely with an estimated $5.08K sold.
- 1 institutional investor held China SXT Pharmaceuticals (SXTC) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $13.1K of China SXT Pharmaceuticals stock for Q1 2025, up 159% quarter-over-quarter.
- 1 fund opened new China SXT Pharmaceuticals positions in Q1 2025 and 1 closed out, a net change of 0 holders.
- The largest China SXT Pharmaceuticals buyer in Q1 2025 was UBS Group, an estimated $18.2K added.
- The largest China SXT Pharmaceuticals seller in Q1 2025 was Bank of Montreal, an estimated $5.08K sold.
Based on aggregated 13F filings for Q1 2025.